Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Erythropoietin Induced Hypertension

NCT03810911 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03810911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Erythropoietin Induced Hypertension
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Terminated
Start date
January 4, 2021
Completion date
July 31, 2025
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, blood pressure, chronic kidney disease